Literature DB >> 8525095

Relationship between clinical manifestations of footrot and specific DNA products of Dichelobacter nodosus amplified through PCR.

D Liu1, C Roycroft, J Samuel, J Webber.   

Abstract

A total of 141 Dichelobacter nodosus isolates from 46 merino sheep farms with various clinical forms of footrot was examined by the gelatin gel test and the polymerase chain reaction (PCR) using virulent (Vf2 and Vr2) and benign (Bf and Br) specific primers. Isolates from sheep with virulent and high intermediate footrot usually produced relatively thermostable proteases, but a decreasing proportion of the isolates from sheep with medium and low intermediate or benign footrot had thermostable proteases, as determined by the gelatin gel test. The amplification by PCR of a major band of 857 bp by Vf2 and Vr2 was often associated with isolates from the more virulent forms of footrot whereas the presence of a major band of 1300 bp by Vf2 and Vr2 and/or a band of 609 bp by Bf and Br was associated with isolates from less virulent forms of footrot. Nevertheless, the virulent and benign gene regions represented by Vf2 and Vr2 and Bf and Br are only two of the many factors involved in determining the virulence of D nodosus. As a result the relationship observed between the clinical manifestations of footrot and specific DNA products amplified by PCR was not complete.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8525095     DOI: 10.1016/0034-5288(95)90040-3

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  Assessment of a rtPCR for the detection of virulent and benign Dichelobacter nodosus, the causative agent of ovine footrot, in Australia.

Authors:  Nickala Best; Lucas Zanandrez; Jacek Gwozdz; Eckard Klien; Nicky Buller; Robert Suter; Grant Rawlin; Travis Beddoe
Journal:  BMC Vet Res       Date:  2018-08-29       Impact factor: 2.741

2.  Characterization of two putative Dichelobacter nodosus footrot vaccine antigens identifies the first lysozyme inhibitor in the genus.

Authors:  Maria Victoria Humbert; Alexandra Jackson; Christian M Orr; Ivo Tews; Myron Christodoulides
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.